SMITH ASSET MANAGEMENT GROUP LP - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 159 filers reported holding ANIKA THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$41,000
-14.6%
1,360
-5.6%
0.00%
-50.0%
Q4 2018$48,000
-21.3%
1,4400.0%0.00%0.0%
Q3 2018$61,000
+32.6%
1,4400.0%0.00%
+100.0%
Q2 2018$46,000
-36.1%
1,4400.0%0.00%
-50.0%
Q1 2018$72,000
-10.0%
1,440
-3.4%
0.00%
-33.3%
Q4 2017$80,000
-7.0%
1,4900.0%0.00%0.0%
Q3 2017$86,000
-39.9%
1,490
-48.6%
0.00%
-25.0%
Q2 2017$143,000
-22.3%
2,900
-31.4%
0.00%
-20.0%
Q1 2017$184,000
-39.9%
4,230
-32.4%
0.01%
-44.4%
Q4 2016$306,000
-1.0%
6,260
-3.1%
0.01%0.0%
Q3 2016$309,000
-9.1%
6,460
+2.1%
0.01%
-10.0%
Q2 2016$340,000
-89.4%
6,330
-91.1%
0.01%
-89.5%
Q1 2016$3,193,000
+17.6%
71,400
+0.4%
0.10%
+18.8%
Q4 2015$2,715,000
+4927.8%
71,150
+4060.8%
0.08%
+3900.0%
Q3 2015$54,000
-8.5%
1,710
-6.2%
0.00%0.0%
Q2 2015$59,000
-98.5%
1,823
-98.0%
0.00%
-98.4%
Q1 2015$3,828,000
-4.2%
93,007
-5.2%
0.13%
-8.6%
Q4 2014$3,997,000
+8.0%
98,127
-2.8%
0.14%
+2.2%
Q3 2014$3,701,000
-20.4%
100,967
+0.7%
0.14%
-19.9%
Q2 2014$4,648,000
-2.7%
100,314
-13.7%
0.17%
-6.0%
Q1 2014$4,777,000
-5.4%
116,223
-12.2%
0.18%
-4.7%
Q4 2013$5,051,000
+40.1%
132,392
-12.3%
0.19%
+28.2%
Q3 2013$3,605,000
+27.4%
150,891
-9.4%
0.15%
+22.1%
Q2 2013$2,830,000166,4730.12%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Caligan Partners LP 1,081,360$20,145,7379.25%
Trigran Investments, Inc. 2,217,019$41,303,0654.40%
DIKER MANAGEMENT LLC 50,239$935,9530.84%
Virtus Investment Advisers, Inc. 45,579$849,1370.58%
Virtus Fund Advisers, LLC 3,490$65,0190.46%
CAPITAL MANAGEMENT CORP /VA 84,225$1,569,1120.35%
Riverwater Partners LLC 17,597$327,8320.30%
BOOTHBAY FUND MANAGEMENT, LLC 617,602$11,505,9250.27%
XTX Topco Ltd 28,033$522,2550.09%
GSA CAPITAL PARTNERS LLP 51,638$9620.08%
View complete list of ANIKA THERAPEUTICS INC shareholders